NO327697B1 - Dihydrobenzodiazepin-2-onderivater, farmasoytisk medikament omfattende slike, fremgangsmate for fremstilling av slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom - Google Patents

Dihydrobenzodiazepin-2-onderivater, farmasoytisk medikament omfattende slike, fremgangsmate for fremstilling av slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom Download PDF

Info

Publication number
NO327697B1
NO327697B1 NO20043237A NO20043237A NO327697B1 NO 327697 B1 NO327697 B1 NO 327697B1 NO 20043237 A NO20043237 A NO 20043237A NO 20043237 A NO20043237 A NO 20043237A NO 327697 B1 NO327697 B1 NO 327697B1
Authority
NO
Norway
Prior art keywords
phenyl
mmol
methyl
butyl ester
trifluoromethyl
Prior art date
Application number
NO20043237A
Other languages
English (en)
Norwegian (no)
Other versions
NO20043237L (no
Inventor
Thomas Johannes Woltering
Erwin Goetschi
Geo Adam
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20043237L publication Critical patent/NO20043237L/no
Publication of NO327697B1 publication Critical patent/NO327697B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO20043237A 2002-02-06 2004-08-02 Dihydrobenzodiazepin-2-onderivater, farmasoytisk medikament omfattende slike, fremgangsmate for fremstilling av slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom NO327697B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02002012 2002-02-06
PCT/EP2003/000859 WO2003066623A1 (en) 2002-02-06 2003-01-28 Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders

Publications (2)

Publication Number Publication Date
NO20043237L NO20043237L (no) 2004-08-02
NO327697B1 true NO327697B1 (no) 2009-09-14

Family

ID=27675598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043237A NO327697B1 (no) 2002-02-06 2004-08-02 Dihydrobenzodiazepin-2-onderivater, farmasoytisk medikament omfattende slike, fremgangsmate for fremstilling av slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom

Country Status (31)

Country Link
US (1) US6949542B2 (ja)
EP (1) EP1474416B1 (ja)
JP (1) JP4077411B2 (ja)
KR (1) KR20040081486A (ja)
CN (1) CN100497333C (ja)
AR (1) AR038481A1 (ja)
AT (1) ATE374196T1 (ja)
AU (1) AU2003205695B8 (ja)
BR (1) BR0307474A (ja)
CA (1) CA2474219C (ja)
DE (1) DE60316538T2 (ja)
DK (1) DK1474416T3 (ja)
ES (1) ES2294264T3 (ja)
GT (1) GT200300028A (ja)
HK (1) HK1078858A1 (ja)
HR (1) HRP20040678A2 (ja)
IL (1) IL163102A (ja)
MX (1) MXPA04007516A (ja)
MY (1) MY176608A (ja)
NO (1) NO327697B1 (ja)
NZ (1) NZ534122A (ja)
PA (1) PA8565901A1 (ja)
PE (1) PE20031011A1 (ja)
PL (1) PL372425A1 (ja)
PT (1) PT1474416E (ja)
RU (1) RU2315764C2 (ja)
SI (1) SI1474416T1 (ja)
TW (1) TWI326599B (ja)
UY (1) UY27654A1 (ja)
WO (1) WO2003066623A1 (ja)
ZA (1) ZA200406032B (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20021663A3 (cs) 1999-10-15 2002-09-11 F. Hoffmann-La Roche Ag Nové deriváty benzodiazepinu
AU2004262897B9 (en) * 2003-07-25 2009-12-17 F. Hoffmann-La Roche Ag Combination of mGluR2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders
WO2007039439A1 (en) 2005-09-27 2007-04-12 F.Hoffmann-La Roche Ag Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN101657432B (zh) * 2007-04-19 2013-04-10 弗·哈夫曼-拉罗切有限公司 二氢-苯并[b][1,4]二氮杂*-2-酮磺酰胺衍生物
CA2697167C (en) 2007-08-27 2013-07-16 F. Hoffmann-La Roche Ag Benzimidazole derivatives used as fxr agonists
TW200927731A (en) 2007-09-14 2009-07-01 Ortho Mcneil Janssen Pharm 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
WO2009033702A1 (en) 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
PT2203439E (pt) 2007-09-14 2011-02-11 Ortho Mcneil Janssen Pharm 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridinil-2'- onas 1',3'-dissubstituídas
EP2220083B1 (en) 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102238950B (zh) 2008-08-04 2014-05-07 Chdi基金会股份有限公司 某些犬尿氨酸-3-单加氧酶抑制剂、药物组合物以及使用方法
EP2344470B1 (en) 2008-09-02 2013-11-06 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2760741C (en) 2009-05-12 2018-05-01 Addex Pharma S.A. 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
RU2553676C2 (ru) 2009-08-21 2015-06-20 Оцука Фармасьютикал Ко., Лтд. СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНОГО БЕНЗО[b][1,4]ДИАЗЕПИН-2,4-ДИОНА
NZ601547A (en) 2010-01-25 2014-04-30 Chdi Foundation Inc Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JP5852665B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
EP2701699B1 (en) 2011-04-28 2019-10-16 The Broad Institute, Inc. Inhibitors of histone deacetylase
CA2847247C (en) 2011-08-29 2019-10-15 Sanford-Burnham Medical Research Institute Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
ES2765805T3 (es) 2011-08-30 2020-06-11 Chdi Foundation Inc Inhibidores de kinurenina-3-monoxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
CN103827095A (zh) 2011-08-30 2014-05-28 Chdi基金会股份有限公司 犬尿氨酸-3-单加氧酶抑制剂、其药物组合物及其使用方法
US9790184B2 (en) 2012-07-27 2017-10-17 The Broad Institute, Inc. Inhibitors of histone deacetylase
AU2013336863A1 (en) 2012-10-23 2015-03-19 F. Hoffmann-La Roche Ag MGlu2/3 antagonists for the treatment of autistic disorders
WO2014100438A1 (en) 2012-12-20 2014-06-26 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20200036063A (ko) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
JP6629740B2 (ja) 2014-01-21 2020-01-15 ヤンセン ファーマシューティカ エヌ.ベー. 代謝型グルタミン酸作動性受容体サブタイプ2の正のアロステリック調節因子またはオルトステリックアゴニストを含む組み合わせ、およびそれらの使用
EP3134089A2 (en) 2014-04-23 2017-03-01 F. Hoffmann-La Roche AG Mglu2/3 antagonists for the treatment of intellectual disabilities
CA2950952C (en) 2014-06-10 2023-01-10 Sanford-Burnham Medical Research Institute Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
BR112017000922A2 (pt) 2014-07-17 2018-01-16 Chdi Foundation, Inc. métodos e composições para tratar distúrbios relacionados ao hiv
JP2017206438A (ja) * 2014-08-22 2017-11-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 テトラヒドロイミダゾ[1,5−d][1,4]オキサゼピン化合物(TETRAHYDROIMIDAZO[1,5−d][1,4]OXAZEPINECOMPOUND)
WO2018019721A1 (en) 2016-07-26 2018-02-01 Basf Se Herbicidal pyridine compounds
WO2018019755A1 (en) 2016-07-26 2018-02-01 Basf Se Herbicidal pyridine compounds
CN110407740A (zh) * 2019-09-04 2019-11-05 上海毕得医药科技有限公司 一种3-溴-2-乙基吡啶的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389189B1 (en) * 1989-03-23 1994-05-18 Pfizer Limited Diazepine antiallergy agents
ATE250039T1 (de) 1999-10-15 2003-10-15 Hoffmann La Roche Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
CZ20021663A3 (cs) 1999-10-15 2002-09-11 F. Hoffmann-La Roche Ag Nové deriváty benzodiazepinu

Also Published As

Publication number Publication date
RU2315764C2 (ru) 2008-01-27
AR038481A1 (es) 2005-01-19
PL372425A1 (en) 2005-07-25
AU2003205695B2 (en) 2008-04-03
DE60316538D1 (de) 2007-11-08
ES2294264T3 (es) 2008-04-01
CN100497333C (zh) 2009-06-10
SI1474416T1 (sl) 2008-02-29
DE60316538T2 (de) 2008-08-21
CA2474219C (en) 2010-04-13
WO2003066623A1 (en) 2003-08-14
PT1474416E (pt) 2007-12-27
ATE374196T1 (de) 2007-10-15
AU2003205695B8 (en) 2008-05-01
TWI326599B (en) 2010-07-01
HRP20040678A2 (en) 2005-10-31
CN1633430A (zh) 2005-06-29
EP1474416B1 (en) 2007-09-26
IL163102A (en) 2011-07-31
JP2005522440A (ja) 2005-07-28
GT200300028A (es) 2004-06-11
CA2474219A1 (en) 2003-08-14
EP1474416A1 (en) 2004-11-10
MXPA04007516A (es) 2004-11-10
MY176608A (en) 2020-08-18
TW200302730A (en) 2003-08-16
PA8565901A1 (es) 2003-09-05
UY27654A1 (es) 2003-08-29
BR0307474A (pt) 2004-11-09
KR20040081486A (ko) 2004-09-21
ZA200406032B (en) 2005-10-12
DK1474416T3 (da) 2008-01-14
AU2003205695A1 (en) 2003-09-02
HK1078858A1 (en) 2006-03-24
NZ534122A (en) 2006-12-22
US6949542B2 (en) 2005-09-27
RU2004126945A (ru) 2005-06-27
US20030166639A1 (en) 2003-09-04
NO20043237L (no) 2004-08-02
JP4077411B2 (ja) 2008-04-16
PE20031011A1 (es) 2003-11-29

Similar Documents

Publication Publication Date Title
NO327697B1 (no) Dihydrobenzodiazepin-2-onderivater, farmasoytisk medikament omfattende slike, fremgangsmate for fremstilling av slike samt anvendelse av slike for fremstilling av medikament for behandling av sykdom
TWI834784B (zh) 經取代之吡唑并嘧啶及經取代之嘌呤以及其作為泛素特異性加工蛋白酶1 ( u s p 1 ) 抑制劑的用途
EP1379511B1 (en) DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
EP1379522B1 (en) DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
AU2002312788A1 (en) Dihydro-benzo [b] [1, 4] diazepin-2-one derivatives as mGluR2 antagonists II
EP3049391B1 (en) Indole and indazole derivatives
NO326518B1 (no) Pyrazolderivater og anvendelse derav, samt farmasoytisk sammensetning
JP7311583B2 (ja) Gaba受容体モジュレーターとしてのジフルオロメチル-フェニルトリアゾール
AU2002310912A1 (en) Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I
AU2010224523A2 (en) Novel anti-inflammatory agents
EP2300435A2 (en) Heterocyclic compounds as factor ixa inhibitors
CN117836294A (zh) 含芳环类生物拮抗剂、其制备方法和应用

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees